Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study

F. Inturrisi*, C.A. Aitken, W.J.G. Melchers, A.J.C. van den Brule, A. Molijn, J.W.J. Hinrichs, H.G.M. Niesters, A.G. Siebers, R. Schuurman, D.A.M. Heideman, I.M.C.M. de Kok, R.L.M. Bekkers, F.J. van Kemenade, J. Berkhof

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Article number100235
Number of pages8
JournalThe Lancet Regional Health – Europe
Volume11
DOIs
Publication statusPublished - 1 Dec 2021

Keywords

  • Human papillomavirus (HPV)
  • Cervical intraepithelial neoplasia
  • CIN3
  • Self-sampling
  • Cervical screening
  • Clinical accuracy
  • Routine screening
  • HUMAN-PAPILLOMAVIRUS
  • CERVICAL-CANCER
  • CYTOLOGY
  • WOMEN
  • ACCEPTABILITY
  • POPULATION
  • SPECIMENS
  • COVID-19
  • DNA

Cite this